REMEDITEX VENTURES
Remeditex was formed to invest in high quality, innovative, early stage projects that are judged to have commercialization potential. The goal is to help investigators establish the commercial viability of their research making it attractive to traditional investors.
REMEDITEX VENTURES
Industry:
Biotechnology Health Care Venture Capital
Founded:
2011-05-12
Status:
Active
Contact:
(214) 506-2662
Email Addresses:
[email protected]
Technology used in webpage:
SPF Euro Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS Amazon Virginia Region
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Polaris Partners
Polaris Partners invests in healthcare and technology companies ​across all stages from founding to profitable growth.
Roche Venture Fund
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche.
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2019-06-17 | Soliton | Remeditex Ventures investment in Post-IPO Equity - Soliton | 9.45 M USD |
| 2017-09-18 | Rodin Therapeutics | Remeditex Ventures investment in Series C - Rodin Therapeutics | 27 M USD |
| 2017-07-18 | VYNE Therapeutics | Remeditex Ventures investment in Series C - VYNE Therapeutics | 50.5 M USD |
| 2016-09-15 | Peloton Therapeutics | Remeditex Ventures investment in Series D - Peloton Therapeutics | 52.4 M USD |
| 2015-12-18 | Navitor Pharmaceuticals | Remeditex Ventures investment in Series B - Navitor Pharmaceuticals | 33 M USD |
| 2015-11-10 | Viridian Therapeutics | Remeditex Ventures investment in Series C - Viridian Therapeutics | 40.7 M USD |
| 2015-11-01 | VYNE Therapeutics | Remeditex Ventures investment in Series B - VYNE Therapeutics | 45 M USD |
| 2015-05-01 | VYNE Therapeutics | Remeditex Ventures investment in Series A - VYNE Therapeutics | 14.3 M USD |
| 2015-02-18 | Viridian Therapeutics | Remeditex Ventures investment in Series B - Viridian Therapeutics | 8.5 M USD |
| 2014-06-27 | Viridian Therapeutics | Remeditex Ventures investment in Series B - Viridian Therapeutics | 7 M USD |